<DOC>
	<DOC>NCT02766855</DOC>
	<brief_summary>The aim of this study is to evaluate the efficacy of topical cysteamine eye drops in the treatment of corneal cystine crystals deposits in patients with nephropathic cystinosis.</brief_summary>
	<brief_title>Efficacy of Topical Cysteamine in Nephropathic Cyctinosis</brief_title>
	<detailed_description>A total of 26 patients with nephropathic cystinosis were included in this prospective study. Patients were evaluated for improvement of corneal cysteine deposits crystals and photophobia following treatment with topical 0.55% cysteamine eye drops.</detailed_description>
	<mesh_term>Cysteamine</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>patients with confirmed diagnosis of nephropathic cystinosis leucocyte cystine concentration level of more than 2.0 nmol halfcystine/ mg protein clinical evidence of tissue deposition of cystine and tissue damage due to cystinosis Allergy to cysteamine</criteria>
	<gender>All</gender>
	<minimum_age>8 Months</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>cysteamine</keyword>
	<keyword>nephropathic cystinosis</keyword>
	<keyword>cystine crystals</keyword>
</DOC>